Prag Bosimi Synthetics Intrinsic Value
Prag Bosimi Synthetics (PRAGBOS) median intrinsic value is ₹1.00 from 1 valuation models (range ₹1–₹1), vs current price ₹1.86 — -46.2% downside (Trading Above Calculated Value), margin of safety -86.0%. For current market price and key ratios, visit Prag Bosimi Synthetics share price today.
PRAGBOS Valuation Methods Summary — DCF, Graham Number & P/E
Prag Bosimi Synthetics intrinsic value across 1 models vs current price ₹1.86 — upside/downside and value range per method. Browse Prag Bosimi Synthetics financial data for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Simple DCF (5Y) | dcf | ₹1.00 | ₹0.80 - ₹1.20 | -46.2% | CF Growth: 5.0%, Discount: 15% |
PRAGBOS Intrinsic Value vs Market Price — All Valuation Models
Prag Bosimi Synthetics fair value range ₹1–₹1 vs current market price ₹1.86 across 1 valuation models. Compare with PRAGBOS stock valuation models to assess whether the stock is under or overvalued.
PRAGBOS Intrinsic Value Analysis — Undervalued or Overvalued?
Prag Bosimi Synthetics median intrinsic value ₹1.00, current price ₹1.86 — Trading Above Calculated Value by 46.2%, margin of safety -86.0%.
What is the intrinsic value of PRAGBOS?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Prag Bosimi Synthetics (PRAGBOS) is ₹1.00 (median value). With the current market price of ₹1.86, this represents a -46.2% variance from our estimated fair value.
The valuation range spans from ₹1.00 to ₹1.00, indicating ₹1.00 - ₹1.00.
Is PRAGBOS undervalued or overvalued?
Based on our multi-method analysis, Prag Bosimi Synthetics (PRAGBOS) appears to be trading above calculated value by approximately 46.2%.
PRAGBOS Financial Health — Key Ratios vs Industry Benchmarks
Prag Bosimi Synthetics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.02 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 300.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
PRAGBOS Cash Flow Quality — Operating & Free Cash Flow
Prag Bosimi Synthetics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹0 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-3 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |